Amgen beat and then raised profit expectations after surging sales of its medicines, tight cost controls and other factors lifted the biologic drugmaker's first-quarter profit by 17 percent.
The maker of osteoporosis drug Prolia on Thursday reported net income of $1.9 billion, or $2.50 per share, trouncing forecasts for the sixth straight quarter.
Amgen posts 1Q sales, profit jumps, raises profit forecasts
Aucun commentaire:
Enregistrer un commentaire